Complications of Cardiovascular Events in Patients Hospitalized with Influenza-Related Pneumonia

References

• Lanks CW, Musani AI, Hsia DW. Community-acquired pneumonia and hospital-acquired pneumonia. Med Clin North Am. 2019;103(3):487–501. doi:10.1016/j.mcna.2018.12.00830955516
   PubMed Web of Science ®Google Scholar
• Corrales-Medina VF, Musher DM, Shachkina S, Chirinos JA. Acute pneumonia and the cardiovascular system. Lancet. 2013;381(9865):496–505. doi:10.1016/S0140-6736(12)61266-523332146
   PubMed Web of Science ®Google Scholar
• Morimoto K, Suzuki M, Ishifuji T, et al. The burden and etiology of community-onset pneumonia in the aging Japanese population: a multicenter prospective study. PLoS One. 2015;10(3):e0122247. doi:10.1371/journal.pone.012224725822890
   PubMed Web of Science ®Google Scholar
• Collaborators GBDV. Five insights from the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1135–1159. doi:10.1016/S0140-6736(20)31404-533069324
   PubMed Web of Science ®Google Scholar
• Aliberti S, Ramirez JA. Cardiac diseases complicating community-acquired pneumonia. Curr Opin Infect Dis. 2014;27(3):295–301. doi:10.1097/QCO.000000000000005524685550
   PubMed Web of Science ®Google Scholar
• Corrales-Medina VF, Suh KN, Rose G, et al. Cardiac complications in patients with community-acquired pneumonia: a systematic review and meta-analysis of observational studies. PLoS Med. 2011;8(6):e1001048. doi:10.1371/journal.pmed.100104821738449
   PubMed Web of Science ®Google Scholar
• Griffin AT, Wiemken TL, Arnold FW. Risk factors for cardiovascular events in hospitalized patients with community-acquired pneumonia. Int J Infect Dis. 2013;17(12):e1125–1129. doi:10.1016/j.ijid.2013.07.00524007923
   PubMed Web of Science ®Google Scholar
• Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2095–2128. doi:10.1016/S0140-6736(12)61728-023245604
   PubMed Web of Science ®Google Scholar
• Chen L, Han X, Bai L, Zhang J. Clinical characteristics and outcomes in adult patients hospitalized with influenza, respiratory syncytial virus and human metapneumovirus infections. Expert Rev Anti Infect Ther. 2020;1–10. doi:10.1080/14787210.2021.1846520
   Web of Science ®Google Scholar
• Nguyen JL, Yang W, Ito K, Matte TD, Shaman J, Kinney PL. Seasonal influenza infections and cardiovascular disease mortality. JAMA Cardiol. 2016;1(3):274–281. doi:10.1001/jamacardio.2016.043327438105
   PubMed Web of Science ®Google Scholar
• Udell JA, Zawi R, Bhatt DL, et al. Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis. JAMA. 2013;310(16):1711–1720. doi:10.1001/jama.2013.27920624150467
   PubMed Web of Science ®Google Scholar
• Chen L, Zhou F, Li H, et al. Disease characteristics and management of hospitalised adolescents and adults with community-acquired pneumonia in China: a retrospective multicentre survey. BMJ Open. 2018;8(2):e018709. doi:10.1136/bmjopen-2017-018709
   PubMed Web of Science ®Google Scholar
• Collins JP, Campbell AP, Openo K, et al. Outcomes of immunocompromised adults hospitalized with laboratory-confirmed influenza in the United States, 2011–2015. Clin Infect Dis. 2020;70(10):2121–2130. doi:10.1093/cid/ciz63831298691
   PubMed Web of Science ®Google Scholar
• Corrales-Medina VF, Musher DM, Wells GA, Chirinos JA, Chen L, Fine MJ. Cardiac complications in patients with community-acquired pneumonia: incidence, timing, risk factors, and association with short-term mortality. Circulation. 2012;125(6):773–781. doi:10.1161/CIRCULATIONAHA.111.04076622219349
   PubMed Web of Science ®Google Scholar
• Katzen J, Kohn R, Houk JL, Ison MG. Early oseltamivir after hospital admission is associated with shortened hospitalization: a 5-year analysis of oseltamivir timing and clinical outcomes. Clin Infect Dis. 2019;69(1):52–58. doi:10.1093/cid/ciy86030304487
   PubMed Web of Science ®Google Scholar
• Jain S, Self WH, Wunderink RG, et al. Community-acquired pneumonia requiring hospitalization among U.S. adults. N Engl J Med. 2015;373(5):415–427. doi:10.1056/NEJMoa150024526172429
   PubMed Web of Science ®Google Scholar
• Chow EJ, Rolfes MA, O’Halloran A, et al. Acute cardiovascular events associated with influenza in hospitalized adults: a Cross-sectional Study. Ann Intern Med. 2020;173(8):605–613. doi:10.7326/M20-150932833488
   PubMed Web of Science ®Google Scholar
• Golia E, Limongelli G, Natale F, et al. Inflammation and cardiovascular disease: from pathogenesis to therapeutic target. Curr Atheroscler Rep. 2014;16(9):435. doi:10.1007/s11883-014-0435-z25037581
   PubMed Web of Science ®Google Scholar
• Putot A, Chague F, Manckoundia P, Cottin Y, Zeller M. Post-infectious myocardial infarction: new insights for improved screening. J Clin Med. 2019;8(6):827. doi:10.3390/jcm8060827
   PubMed Web of Science ®Google Scholar
• Herfst S, van den Brand JM, Schrauwen EJ, et al. Pandemic 2009 H1N1 influenza virus causes diffuse alveolar damage in cynomolgus macaques. Vet Pathol. 2010;47(6):1040–1047. doi:10.1177/030098581037483620647595
   PubMed Web of Science ®Google Scholar
• Demiselle J, Fage N, Radermacher P, Asfar P. Vasopressin and its analogues in shock states: a review. Ann Intensive Care. 2020;10(1):9. doi:10.1186/s13613-020-0628-231970567
   PubMed Web of Science ®Google Scholar
• Shi SJ, Li H, Liu M, et al. Mortality prediction to hospitalized patients with influenza pneumonia: PO2/FiO2 combined lymphocyte count is the answer. Clin Respir J. 2017;11(3):352–360. doi:10.1111/crj.1234626148709
   PubMed Web of Science ®Google Scholar
• Bellelli V, d’Ettorre G, Celani L, Borrazzo C, Ceccarelli G, Venditti M. Clinical significance of lymphocytopenia in patients hospitalized with pneumonia caused by influenza virus. Crit Care. 2019;23(1):330. doi:10.1186/s13054-019-2608-131665060
   PubMed Web of Science ®Google Scholar
• Boonnak K, Vogel L, Feldmann F, Feldmann H, Legge KL, Subbarao K. Lymphopenia associated with highly virulent H5N1 virus infection due to plasmacytoid dendritic cell-mediated apoptosis of T cells. J Immunol. 2014;192(12):5906–5912. doi:10.4049/jimmunol.130299224829418
   PubMed Web of Science ®Google Scholar
• Fox A, Le NM, Horby P, et al. Severe pandemic H1N1 2009 infection is associated with transient NK and T deficiency and aberrant CD8 responses. PLoS One. 2012;7(2):e31535. doi:10.1371/journal.pone.003153522363665
   PubMed Web of Science ®Google Scholar
• Gonzalez Y, Juarez E, Carranza C, Sada E, Pedraza-Sanchez S, Torres M. Diminished effector and memory CD8+ circulating T lymphocytes in patients with severe influenza caused by the AH1N1 pdm09 virus. Virology. 2017;500:139–148. doi:10.1016/j.virol.2016.10.01627816639
   PubMed Web of Science ®Google Scholar
• Chen L, Han X, Li YL, Zhang C, Xing X. FluA-p score: a novel prediction rule for mortality in influenza A-related pneumonia patients. Respir Res. 2020;21(1):109. doi:10.1186/s12931-020-01379-z32384935
   PubMed Web of Science ®Google Scholar
• Guo L, Wei D, Zhang X, et al. Clinical features predicting mortality risk in patients with viral pneumonia: the MuLBSTA Score. Front Microbiol. 2019;10:2752. doi:10.3389/fmicb.2019.0275231849894
   PubMed Web of Science ®Google Scholar
• Gobolos L, Racz I, Hogan M, et al. The role of renin-angiotensin system activated phagocytes in the SARS-CoV-2 coronavirus infection. J Vasc Surg. 2020:S0741-5214(20)32605-7. doi:10.1016/j.jvs.2020.12.056
   Web of Science ®Google Scholar
• Gao YL, Du Y, Zhang C, et al. Role of renin-angiotensin system in acute lung injury caused by viral infection. Infect Drug Resist. 2020;13:3715–3725. doi:10.2147/IDR.S26571833116692
   PubMed Web of Science ®Google Scholar
• Huang F, Guo J, Zou Z, et al. Angiotensin II plasma levels are linked to disease severity and predict fatal outcomes in H7N9-infected patients. Nat Commun. 2014;5(1):3595. doi:10.1038/ncomms459524800963
   PubMed Web of Science ®Google Scholar
• Zou Z, Yan Y, Shu Y, et al. Angiotensin-converting enzyme 2 protects from lethal avian influenza A H5N1 infections. Nat Commun. 2014;5(1):3594. doi:10.1038/ncomms459424800825
   PubMed Web of Science ®Google Scholar
• Shimizu T, Iwamoto N, Okamoto M, et al. Scleroderma renal crisis complicated with thrombotic microangiopathy triggered by influenza B virus infection. Intern Med. 2019;58(3):441–445. doi:10.2169/internalmedicine.1441-1830146597
   PubMed Web of Science ®Google Scholar
• Costopoulos C, Benson A, Prasad S, Ghuran A. Diagnostic dilemmas in cardiology. BMJ Case Rep. 2012;2012:2012. doi:10.1136/bcr-2012-006521
   Google Scholar
• Lang JP, Wang X, Moura FA, Siddiqi HK, Morrow DA, Bohula EA. A current review of COVID-19 for the cardiovascular specialist. Am Heart J. 2020;226:29–44. doi:10.1016/j.ahj.2020.04.02532497913
   PubMed Web of Science ®Google Scholar
• Imai Y, Kuba K, Rao S, et al. Angiotensin-converting enzyme 2 protects from severe acute lung failure. Nature. 2005;436(7047):112–116. doi:10.1038/nature0371216001071
   PubMed Web of Science ®Google Scholar
• Kuba K, Imai Y, Rao S, et al. A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury. Nat Med. 2005;11(8):875–879. doi:10.1038/nm126716007097
   PubMed Web of Science ®Google Scholar
• Sinagra G, Corra U, Contini M, et al. Choosing among beta-blockers in heart failure patients according to beta-receptors’ location and functions in the cardiopulmonary system. Pharmacol Res. 2020;156:104785. doi:10.1016/j.phrs.2020.10478532224252
   PubMed Web of Science ®Google Scholar
• Levi M, Eerenberg E, Kamphuisen PW. Bleeding risk and reversal strategies for old and new anticoagulants and antiplatelet agents. J Thromb Haemost. 2011;9(9):1705–1712. doi:10.1111/j.1538-7836.2011.04432.x21729240
   PubMed Web of Science ®Google Scholar
• Muthuri SG, Venkatesan S, Myles PR, et al. Impact of neuraminidase inhibitors on influenza A(H1N1)pdm09-related pneumonia: an individual participant data meta-analysis. Influenza Other Respir Viruses. 2016;10(3):192–204. doi:10.1111/irv.1236326602067
   PubMed Web of Science ®Google Scholar
• Zhou Y, Fu X, Liu X, et al. Use of corticosteroids in influenza-associated acute respiratory distress syndrome and severe pneumonia: a systemic review and meta-analysis. Sci Rep. 2020;10(1):3044. doi:10.1038/s41598-020-59732-732080223
   PubMed Web of Science ®Google Scholar
• Cangemi R, Falcone M, Taliani G, et al. Corticosteroid use and incident myocardial infarction in adults hospitalized for community-acquired pneumonia. Ann Am Thorac Soc. 2019;16(1):91–98. doi:10.1513/AnnalsATS.201806-419OC30188173
   PubMed Web of Science ®Google Scholar